Merck & Co. Inc: Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister
Recall reason: Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.. Recalled by Merck & Co. Inc. Distribution: Nationwide in the USA and PR.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lots 2090019 and 2123744, Exp. 4/30/2027. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report